Ruixue Deng1, Zhaohui Lu, Yuanjia Chen, Lu Zhou, Xinghua Lu. 1. Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, PR China.
Abstract
OBJECTIVE: Late diagnosis is the major reason for poor prognosis of pancreatic cancer (PC). Developing new biomarkers of early stage detection is critical. METHODS: Proteomic analysis with 2-dimensional gel electrophoresis was used to identify differentially expressed proteins in plasma of PC patients. The 2-dimensional gel electrophoresis plasma protein profiles of 11 PC patients (preoperative and postoperative) were compared with those of 10 patients with chronic pancreatitis (CP) and 11 healthy controls. RESULTS: Five proteins were found to be constantly changed. Haptoglobin (Hp) beta chain and leucine-rich alpha2 glycoprotein up-regulated slightly in PC plasma. Pancreatic cancer had a higher frequency of Hp2-2 phenotype but lacked Hp1-1 phenotype. Hemoglobin was increased significantly in plasma samples of PC and CP. Alpha1 antitrypsin gradually increased its expression level in healthy control, PC, and CP. Immunoglobin J chain was elevated in CP plasma samples. Haptoglobin, alpha1 antitrypsin, and leucine-rich alpha2-glycoprotein were all greatly elevated after tumor resection in PC patients. CONCLUSIONS: Proteomic analysis can simultaneously detect changes of multiproteins in plasma of PC, but detected proteins are abundant and common plasma proteins and their diagnostic value may be limited.
OBJECTIVE: Late diagnosis is the major reason for poor prognosis of pancreatic cancer (PC). Developing new biomarkers of early stage detection is critical. METHODS: Proteomic analysis with 2-dimensional gel electrophoresis was used to identify differentially expressed proteins in plasma of PC patients. The 2-dimensional gel electrophoresis plasma protein profiles of 11 PC patients (preoperative and postoperative) were compared with those of 10 patients with chronic pancreatitis (CP) and 11 healthy controls. RESULTS: Five proteins were found to be constantly changed. Haptoglobin (Hp) beta chain and leucine-rich alpha2 glycoprotein up-regulated slightly in PC plasma. Pancreatic cancer had a higher frequency of Hp2-2 phenotype but lacked Hp1-1 phenotype. Hemoglobin was increased significantly in plasma samples of PC and CP. Alpha1 antitrypsin gradually increased its expression level in healthy control, PC, and CP. Immunoglobin J chain was elevated in CP plasma samples. Haptoglobin, alpha1 antitrypsin, and leucine-rich alpha2-glycoprotein were all greatly elevated after tumor resection in PC patients. CONCLUSIONS: Proteomic analysis can simultaneously detect changes of multiproteins in plasma of PC, but detected proteins are abundant and common plasma proteins and their diagnostic value may be limited.
Authors: Berit Velstra; Bert A Bonsing; Bart J Mertens; Yuri E M van der Burgt; Anouck Huijbers; Hans Vasen; Wilma E Mesker; André M Deelder; Rob A E M Tollenaar Journal: HPB (Oxford) Date: 2012-11-30 Impact factor: 3.647
Authors: Sheng Pan; Ru Chen; David A Crispin; Damon May; Tyler Stevens; Martin W McIntosh; Mary P Bronner; Argyrios Ziogas; Hoda Anton-Culver; Teresa A Brentnall Journal: J Proteome Res Date: 2011-03-28 Impact factor: 4.466
Authors: Matthew A Firpo; David Z Gay; Steven R Granger; Courtney L Scaife; James A DiSario; Kenneth M Boucher; Sean J Mulvihill Journal: World J Surg Date: 2009-04 Impact factor: 3.352
Authors: Sheng Pan; Ru Chen; Beth Ann Reimel; David A Crispin; Hamid Mirzaei; Kelly Cooke; Joshua F Coleman; Zhaoli Lane; Mary P Bronner; David R Goodlett; Martin W McIntosh; William Traverso; Ruedi Aebersold; Teresa A Brentnall Journal: Electrophoresis Date: 2009-04 Impact factor: 3.535
Authors: Berit Velstra; Marieke A Vonk; Bert A Bonsing; Bart J Mertens; Simone Nicolardi; Anouck Huijbers; Hans Vasen; André M Deelder; Wilma E Mesker; Yuri E M van der Burgt; Rob A E M Tollenaar Journal: J Cancer Res Clin Oncol Date: 2014-09-21 Impact factor: 4.553
Authors: Mayank Saraswat; Sakari Joenväärä; Hanna Seppänen; Harri Mustonen; Caj Haglund; Risto Renkonen Journal: Cancer Med Date: 2017-06-01 Impact factor: 4.452